Botulinum Toxin for Urinary Tract Disease
Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techn...
में बचाया:
| स्वरूप: | Online |
|---|---|
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| विषय: | |
| ऑनलाइन पहुंच: | ONIX_20260416T142754_9783725863389_7 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
| _version_ | 1869515576633720832 |
|---|---|
| collection | Directory of Open Access Books |
| description | Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techniques have become established, and how were they optimized? Are more practical ways of distribution on the way? What acceptance problems or obstacles to long-term use might exist among patients or doctors? What are the risks? Has the therapy gained a foothold in the outpatient sector? |
| format | Online |
| id | doab-20.500.12854ir-175252 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1752522026-04-16T19:54:04Z Botulinum Toxin for Urinary Tract Disease Schulte-Baukloh, Heinrich Botulinum toxin Sensory Bladder Nerve Mechanosensitivity Overactive bladder Detrusor overactivity Neurogenic bladder dysfunction Detrusor wall thickness Injection Female urinary incontinence Urgency urinary incontinence Bladder botulinum toxin Botox® Adverse effects Neurogenic detrusor overactivity Idiopathic overactive bladder OnabotulinumtoxinA Meta-analysis BotulinumtoxinA detrusor injection Needle thickness Pain Local anesthesia Underactive bladder Chronic urine retention Botulinum toxin A Transvaginal ultrasound guidance External sphincter injection Transurethral incision of the bladder neck Neurogenic bladder Anxiety General anesthesia Urge incontinence Botox Procedure considerations Minimally invasive therapy OnabotulinumtoxinA intravesical injection Urge urinary incontinence Idiopathic Injection paradigm Trigone Suburothelial N A thema EDItEUR::M Medicine and Nursing Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techniques have become established, and how were they optimized? Are more practical ways of distribution on the way? What acceptance problems or obstacles to long-term use might exist among patients or doctors? What are the risks? Has the therapy gained a foothold in the outpatient sector? 2026-04-16T19:53:56Z 2026-04-16T19:53:56Z 2026 book ONIX_20260416T142754_9783725863389_7 9783725863389 9783725863396 https://directory.doabooks.org/handle/20.500.12854/175252 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/ https://mdpi.com/books/pdfview/book/12164 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-6339-6 10.3390/books978-3-7258-6339-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725863389 9783725863396 138 CH open access |
| spellingShingle | Botulinum toxin Sensory Bladder Nerve Mechanosensitivity Overactive bladder Detrusor overactivity Neurogenic bladder dysfunction Detrusor wall thickness Injection Female urinary incontinence Urgency urinary incontinence Bladder botulinum toxin Botox® Adverse effects Neurogenic detrusor overactivity Idiopathic overactive bladder OnabotulinumtoxinA Meta-analysis BotulinumtoxinA detrusor injection Needle thickness Pain Local anesthesia Underactive bladder Chronic urine retention Botulinum toxin A Transvaginal ultrasound guidance External sphincter injection Transurethral incision of the bladder neck Neurogenic bladder Anxiety General anesthesia Urge incontinence Botox Procedure considerations Minimally invasive therapy OnabotulinumtoxinA intravesical injection Urge urinary incontinence Idiopathic Injection paradigm Trigone Suburothelial N A thema EDItEUR::M Medicine and Nursing Botulinum Toxin for Urinary Tract Disease |
| title | Botulinum Toxin for Urinary Tract Disease |
| title_full | Botulinum Toxin for Urinary Tract Disease |
| title_fullStr | Botulinum Toxin for Urinary Tract Disease |
| title_full_unstemmed | Botulinum Toxin for Urinary Tract Disease |
| title_short | Botulinum Toxin for Urinary Tract Disease |
| title_sort | botulinum toxin for urinary tract disease |
| topic | Botulinum toxin Sensory Bladder Nerve Mechanosensitivity Overactive bladder Detrusor overactivity Neurogenic bladder dysfunction Detrusor wall thickness Injection Female urinary incontinence Urgency urinary incontinence Bladder botulinum toxin Botox® Adverse effects Neurogenic detrusor overactivity Idiopathic overactive bladder OnabotulinumtoxinA Meta-analysis BotulinumtoxinA detrusor injection Needle thickness Pain Local anesthesia Underactive bladder Chronic urine retention Botulinum toxin A Transvaginal ultrasound guidance External sphincter injection Transurethral incision of the bladder neck Neurogenic bladder Anxiety General anesthesia Urge incontinence Botox Procedure considerations Minimally invasive therapy OnabotulinumtoxinA intravesical injection Urge urinary incontinence Idiopathic Injection paradigm Trigone Suburothelial N A thema EDItEUR::M Medicine and Nursing |
| topic_facet | Botulinum toxin Sensory Bladder Nerve Mechanosensitivity Overactive bladder Detrusor overactivity Neurogenic bladder dysfunction Detrusor wall thickness Injection Female urinary incontinence Urgency urinary incontinence Bladder botulinum toxin Botox® Adverse effects Neurogenic detrusor overactivity Idiopathic overactive bladder OnabotulinumtoxinA Meta-analysis BotulinumtoxinA detrusor injection Needle thickness Pain Local anesthesia Underactive bladder Chronic urine retention Botulinum toxin A Transvaginal ultrasound guidance External sphincter injection Transurethral incision of the bladder neck Neurogenic bladder Anxiety General anesthesia Urge incontinence Botox Procedure considerations Minimally invasive therapy OnabotulinumtoxinA intravesical injection Urge urinary incontinence Idiopathic Injection paradigm Trigone Suburothelial N A thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20260416T142754_9783725863389_7 |